The ADAM17-directed Inhibitory Antibody MEDI3622 Antagonizes Radiotherapy-induced VEGF Release and Sensitizes Non–Small Cell Lung Cancer for Radiotherapy
Cancer Research Communications (2021) 1 (3): 164–177.
Currently there are no citedby results. Try again later.
